Stock Analysis

Tecnotree Oyj Just Missed Earnings - But Analysts Have Updated Their Models

Tecnotree Oyj (HEL:TEM1V) just released its latest quarterly report and things are not looking great. Results showed a clear earnings miss, with €19m revenue coming in 7.5% lower than what the analystexpected. Statutory earnings per share (EPS) of €0.20 missed the mark badly, arriving some 31% below what was expected. Earnings are an important time for investors, as they can track a company's performance, look at what the analyst is forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimate to see what could be in store for next year.

earnings-and-revenue-growth
HLSE:TEM1V Earnings and Revenue Growth October 31st 2025

Taking into account the latest results, the most recent consensus for Tecnotree Oyj from solitary analyst is for revenues of €81.0m in 2026. If met, it would imply a decent 15% increase on its revenue over the past 12 months. Per-share earnings are expected to jump 52% to €0.61. Before this earnings report, the analyst had been forecasting revenues of €82.0m and earnings per share (EPS) of €0.68 in 2026. The analyst seem to have become more bearish following the latest results. While there were no changes to revenue forecasts, there was a real cut to EPS estimates.

Check out our latest analysis for Tecnotree Oyj

Despite cutting their earnings forecasts,the analyst has lifted their price target 18% to €4.50, suggesting that these impacts are not expected to weigh on the stock's value in the long term.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. The analyst is definitely expecting Tecnotree Oyj's growth to accelerate, with the forecast 12% annualised growth to the end of 2026 ranking favourably alongside historical growth of 6.5% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 12% annually. Tecnotree Oyj is expected to grow at about the same rate as its industry, so it's not clear that we can draw any conclusions from its growth relative to competitors.

Advertisement

The Bottom Line

The biggest concern is that the analyst reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Tecnotree Oyj. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. There was also a nice increase in the price target, with the analyst clearly feeling that the intrinsic value of the business is improving.

With that in mind, we wouldn't be too quick to come to a conclusion on Tecnotree Oyj. Long-term earnings power is much more important than next year's profits. At least one analyst has provided forecasts out to 2027, which can be seen for free on our platform here.

Even so, be aware that Tecnotree Oyj is showing 4 warning signs in our investment analysis , and 1 of those is a bit concerning...

Valuation is complex, but we're here to simplify it.

Discover if Tecnotree Oyj might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.